A role for the NPM1/PTPN14/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma.
Dengke ZhangFazong WuJingjing SongMiaomiao MengXiaoxi FanChenying LuQiaoyou WengShiji FangLiyun ZhengBufu TangYang YangJianfei TuMin XuZhongwei ZhaoJian-Song JiPublished in: Cancer cell international (2022)
These data suggest that a therapeutic strategy against chemoresistant HCC may involve disruption of NPM1-mediated regulation of YAP by retaining PTPN14 in the nucleus under hypoxic conditions.